• 优途加速器app

    Uniting stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of—and future access to—an HIV vaccine

    Learn moreStrategic Plan
    Diagram of the plan

A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

赛·风4 for android

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

优途加速器app

优途加速器app

/in News /by

With over 600 virtual sessions and events, AIDS 2024: Virtual will enable delegates to access and engage with the latest HIV science, advocacy and knowledge traditionally presented at the conference, while offering a range of new features made possible by the new virtual format. Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Download the HIV vaccine, and vaccine research roadmap.

Read more

优途加速器app

优途加速器app

/in Events /by

This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Read more

优途加速器app

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.
Submit a timely topic

优途加速器app

C. Bickel, Science Translational Medicine; National Institute of Allergy and Infectious Diseases

优途加速器app

Book case (illustration)

优途加速器app

African children (illustration)

2nd Infant Trials Workshop

賽风官网下载

Knowns and Unknowns of Assaying ADCC against HIV

优途加速器app

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

© Copyright - The Global HIV Vaccine Enterprise - Enfold Theme by Kriesi
Scroll to top
WP Twitter Auto Publish Powered By : XYZScripts.com
    • sky彗星加速器  烧饼哥vqn下载佛跳墙极光入口  xbee小蜜蜂破解版  snapchat的加速器安装  ins下载vivo  喵咪破解版  云梯vp加速器官网,云梯vp,云梯vp加速器下载,云梯vp免费下载